Aridis Pharmaceuticals, Inc.

OTCPK:ARDS Voorraadrapport

Marktkapitalisatie: US$10.7k

Aridis Pharmaceuticals Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Vu Truong

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO21.8yrs
Eigendom CEO2.6%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur8.3yrs

Recente managementupdates

Recent updates

Aridis Pharmaceuticals announces proposed public stock offering; shares down ~30%

Sep 26

Aridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M

Aug 16

Can You Imagine How Aridis Pharmaceuticals' (NASDAQ:ARDS) Shareholders Feel About The 32% Share Price Increase?

Feb 17
Can You Imagine How Aridis Pharmaceuticals' (NASDAQ:ARDS) Shareholders Feel About The 32% Share Price Increase?

Aridis Pharmaceuticals EPS misses by $0.02

Nov 20

Aridis Pharmaceuticals (ARDS) Investor Presentation - Slideshow

Oct 31

Analyse CEO-vergoeding

Hoe is Vu Truong's beloning veranderd ten opzichte van Aridis Pharmaceuticals's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2023n/an/a

-US$1m

Jun 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$753kUS$525k

-US$30m

Sep 30 2022n/an/a

-US$33m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$46m

Dec 31 2021US$842kUS$500k

-US$46m

Sep 30 2021n/an/a

-US$43m

Jun 30 2021n/an/a

-US$25m

Mar 31 2021n/an/a

-US$24m

Dec 31 2020US$783kUS$475k

-US$22m

Sep 30 2020n/an/a

-US$22m

Jun 30 2020n/an/a

-US$24m

Mar 31 2020n/an/a

-US$28m

Dec 31 2019US$2mUS$450k

-US$30m

Sep 30 2019n/an/a

-US$29m

Jun 30 2019n/an/a

-US$30m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$2mUS$450k

-US$23m

Sep 30 2018n/an/a

-US$24m

Jun 30 2018n/an/a

-US$22m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$490kUS$350k

-US$27m

Compensatie versus markt: Insufficient data to establish whether Vu's total compensation is reasonable compared to companies of similar size in the US market.

Compensatie versus inkomsten: Vu's compensation has been consistent with company performance over the past year.

CEO

Vu Truong (60 yo)

21.8yrs

Tenure

US$752,516

Compensatie

Dr. Vu L. Truong, Ph D., is the Founder at Aridis Pharmaceuticals, Inc. and also serves as its Chief Executive Officer and Chief Scientific Officer since 2003. He has more than 15 years of experience in b...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Eric Patzer
Founder & Executive Chairman19.8yrsUS$262.80k1.66%
$ 176.9
Vu Truong
Founder10.8yrsUS$752.52k2.59%
$ 275.7
John Patton
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
John Hamilton
Independent Director9.4yrsUS$40.50k0.0037%
$ 0.4
Harry Greenberg
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Susan Windham-Bannister
Independent Director5.4yrsUS$37.50k0%
$ 0
Marin Kollef
Member of Clinical Advisory Board8.3yrsgeen gegevensgeen gegevens
Alan Cohen
Member of Clinical Advisory Boardno dataUS$703.17kgeen gegevens
Jerry Pier
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
Steven Opal
Member Scientific Advisory Boardno datageen gegevensgeen gegevens
Bruno Francois
Member of Clinical Advisory Board8.3yrsgeen gegevensgeen gegevens
Jean Chastre
Member of Clinical Advisory Board8.3yrsgeen gegevensgeen gegevens

8.3yrs

Gemiddelde duur

73yo

Gemiddelde leeftijd

Ervaren bestuur: ARDS's board of directors are considered experienced (8.3 years average tenure).